BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10475380)

  • 1. Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma.
    Schuhmacher C; Becker KF; Reich U; Schenk U; Mueller J; Siewert JR; Höfler H
    Diagn Mol Pathol; 1999 Jun; 8(2):66-70. PubMed ID: 10475380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
    Becker KF; Atkinson MJ; Reich U; Becker I; Nekarda H; Siewert JR; Höfler H
    Cancer Res; 1994 Jul; 54(14):3845-52. PubMed ID: 8033105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy].
    Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():148-54. PubMed ID: 10714205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
    Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
    Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
    Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
    Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
    Jpn J Cancer Res; 1996 Nov; 87(11):1153-9. PubMed ID: 9045944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma.
    Fukudome Y; Yanagihara K; Takeichi M; Ito F; Shibamoto S
    Int J Cancer; 2000 Nov; 88(4):579-83. PubMed ID: 11058874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer.
    Tokuda K; Natsugoe S; Nakajo A; Miyazono F; Ishigami S; Hokita S; Takao S; Eizuru Y; Aikou T
    Int J Mol Med; 2003 Jan; 11(1):79-84. PubMed ID: 12469223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors].
    Becker I; Becker KF; Kremmer E; Eulitz M; Handschuh G; Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():233-9. PubMed ID: 10714216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of gastric cancer cells in intraoperative peritoneal lavage using the reverse transcription--loop-mediated isothermal amplification method.
    Yoneda A; Taniguchi K; Torashima Y; Susumu S; Kanetaka K; Kuroki T; Eguchi S
    J Surg Res; 2014 Mar; 187(1):e1-6. PubMed ID: 24360119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer.
    Sugita Y; Fujiwara Y; Taniguchi H; Mori T; Ishii T; Niwa H; Okada Y; Takiguchi S; Yasuda T; Yano M; Monden M
    Int J Oncol; 2003 Nov; 23(5):1419-23. PubMed ID: 14532985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative quantitative detection of CEA mRNA in the peritoneal lavage of gastric cancer patients with transcription reverse-transcription concerted (TRC) method. A comparative study with real-time quantitative RT-PCR.
    Ohashi N; Nakanishi H; Kodera Y; Ito S; Mochizuki Y; Koike M; Fujiwara M; Yamamura Y; Tatematsu M; Nakao A; Kato T
    Anticancer Res; 2007; 27(4C):2769-77. PubMed ID: 17695446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
    Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
    Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
    Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
    Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
    Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
    J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody.
    Becker KF; Kremmer E; Eulitz M; Becker I; Handschuh G; Schuhmacher C; Müller W; Gabbert HE; Ochiai A; Hirohashi S; Höfler H
    Am J Pathol; 1999 Dec; 155(6):1803-9. PubMed ID: 10595908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin gene mutations in human gastric carcinoma cell lines.
    Oda T; Kanai Y; Oyama T; Yoshiura K; Shimoyama Y; Birchmeier W; Sugimura T; Hirohashi S
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1858-62. PubMed ID: 8127895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis.
    Marutsuka T; Shimada S; Shiomori K; Hayashi N; Yagi Y; Yamane T; Ogawa M
    Clin Cancer Res; 2003 Feb; 9(2):678-85. PubMed ID: 12576435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings.
    Mori K; Aoyagi K; Ueda T; Danjoh I; Tsubosa Y; Yanagihara K; Matsuno Y; Sasako M; Sakamoto H; Mafune Ki; Kaminishi M; Yoshida T; Terada M; Sasaki H
    Biochem Biophys Res Commun; 2004 Jan; 313(4):931-7. PubMed ID: 14706632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis.
    Ishii T; Fujiwara Y; Ohnaka S; Hayashi T; Taniguchi H; Takiguchi S; Yasuda T; Yano M; Monden M
    Ann Surg Oncol; 2004 Aug; 11(8):778-85. PubMed ID: 15289240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.